C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2011
11/08/2011	US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011	US8053445 Utilities of olefin derivatives
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011	CA2516263C Benzofuranoxyethylamines as antidepressants and anxiolytics
11/08/2011	CA2509072C Saturated and unsaturated heteroarylcycloalkylmethyl-amines as antidepressants
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2476430C Sodium channel blockers
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011	CA2405408C Pyrazole compounds
11/03/2011	WO2011137088A1 Herbicidal uracils
11/03/2011	WO2011137072A1 Bicarbazole containing compounds for oleds
11/03/2011	WO2011136319A1 Anticancer agent
11/03/2011	WO2011136264A1 [5,6] heterocyclic compound
11/03/2011	WO2011135376A1 Pyrazolyl quinazoline kinase inhibitors
11/03/2011	WO2011104725A3 Intermediates for the preparation of hmg-coa reductase inhibitors and processes for the preparation thereof
11/03/2011	WO2011075699A3 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/03/2011	WO2011062437A3 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
11/03/2011	WO2010052569A8 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
11/03/2011	US20110269960 Triazole derivative
11/03/2011	US20110269775 Piperazine derivatives
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/03/2011	US20110269753 Heterocyclic compounds as phosphodiesterase inhibitors
11/03/2011	US20110269747 Polyarylcarboxamides useful as lipid lowering agents
11/03/2011	US20110269746 Cyclic compound having hetero atom
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269707 Modified nucleosides for the treatment of viral infections and abnormal cellullar proliferation
11/03/2011	US20110269677 Oligomer-Protease Inhibitor Conjugates
11/03/2011	US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/03/2011	CA2791020A1 [5,6] heterocyclic compound
11/02/2011	EP2383268A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
11/02/2011	EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds
11/02/2011	EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
11/02/2011	EP2382190A1 Toluidine sulfonamides and their use as-inhibitors
11/02/2011	EP2381944A1 Anti-viral compounds, treatment, and assay
11/02/2011	EP2381783A1 Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits
11/02/2011	EP2381778A1 C5ar antagonists
11/02/2011	EP2178841B1 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast
11/02/2011	EP1758883B1 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
11/02/2011	EP1732901B1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
11/02/2011	EP1535914B1 Processes for producing epoxytriazole derivative and intermediate therefor
11/02/2011	CN102232072A (R)-3-(E)-2-(pyrr0lidin-3-yl) vinyl)-5-(tetrahydr0pyran-4-yl0xy) pyridine, its salts, its synthesis and its use as ligand for nicotinic acetylcholinergic receptors
11/02/2011	CN102229603A Triazole heterocycle-containing 2-methyl benzofuran compound, and preparation and application thereof
11/02/2011	CN102229602A Tacrine heterocomplex, preparation method and use in medicines for curing neurodegenerative diseases thereof
11/02/2011	CN102229599A 1,4- dihydropyridine ring-containing cis-nitenpyram compound, preparation method and application thereof
11/02/2011	CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors
11/02/2011	CN102229576A Method for synthesizing 1,2,4-triazine compound by using micro-reactor
11/02/2011	CN101735207B Desloratadine derivative containing gamma-subunit butenolide and synthesizing method thereof
11/02/2011	CN101160306B Benzimidazole compound
11/02/2011	CN101058573B 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
11/01/2011	USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/01/2011	US8049010 Using 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-formaldehyde as raw material; cyanation to 4-4'-fluorophenyl-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-acrylonitrile; carbonylation, chain extension, hydrolysis, neutralization, decomposition, catalysis
11/01/2011	US8048904 Process for the preparation of olmesartan medoxomil
11/01/2011	US8048887 Compounds for the treatment of hepatitis C
11/01/2011	CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011	CA2645257C Sulfonyl benzimidazole derivatives
11/01/2011	CA2640435C Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
11/01/2011	CA2629462C Beta-secretase modulators and methods of use
11/01/2011	CA2545644C Melanocortin receptor agonists
11/01/2011	CA2479012C Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
11/01/2011	CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase
11/01/2011	CA2473591C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2409741C Tnf-.alpha. production inhibitors
11/01/2011	CA2404938C Production of polyketides
10/2011
10/27/2011	WO2011133751A2 Process of producing cycloalkylcarboxamido-indole compounds
10/27/2011	WO2011133659A2 Inhibitors of hif and angiogenesis
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011131748A2 Novel inhibitors
10/27/2011	WO2011131741A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
10/27/2011	WO2011131605A1 Production of atorvastatin low in ether impurities
10/27/2011	WO2011131601A1 Production of atorvastatin low in lactone impurities
10/27/2011	WO2011131135A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
10/27/2011	WO2011130908A1 Substituted pyrimidines
10/27/2011	WO2011130831A1 Polymorphic forms of lapatinib ditosylate and processes for their preparation
10/27/2011	WO2011056985A3 Substituted heterocyclic compounds
10/27/2011	US20110263672 Metabolites of Wortmannin Analogs and Methods of Using the Same
10/27/2011	US20110263666 process for the preparation or purification of olmesartan medoxomil
10/27/2011	US20110263653 Migrastatin analog compositions and uses thereof
10/27/2011	US20110263614 Novel compounds
10/27/2011	US20110263612 Compounds that modulate intracellular calcium
10/27/2011	US20110263610 Compounds and compositions as itpkb inhibitors
10/27/2011	US20110263597 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263564 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
10/27/2011	US20110263563 Ansamycin Hydroquinone Compositions
10/27/2011	US20110263560 Organic Compounds
10/27/2011	US20110263532 Halofuginone analogs for inhibition of trna synthetases and uses thereof
10/27/2011	US20110263431 Pyrrole derivatives for use as plant growth regulators
10/27/2011	US20110263428 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
10/27/2011	US20110262482 Anti-viral compounds
10/27/2011	US20110262388 Novel inhibitors
10/27/2011	US20110262352 Aryl piperazine and their use as alpha2c antagonists
10/27/2011	CA2797090A1 Polymorphic forms of lapatinib ditosylate and processes for their preparation
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2380881A1 Novel bicyclic heterocyclic compound
10/26/2011	EP2380878A1 Cyclic compound having hetero atom
10/26/2011	EP2379535A1 7-phenoxychroman carboxylic acid derivatives
10/26/2011	EP2379534A1 Heterocyclic antiviral compounds
10/26/2011	EP2379530A1 Pyrimidine indole derivatives for treating cancer
10/26/2011	EP2379527A1 Pyrimidin- 2 -ylamino derivatives and their use to treat inflammation

1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 694